Abstract:Freeze-drying is the method of choice to dry formulations with biopharmaceutical drugs, to enhance protein stability. This is usually done below the glass transition temperature of maximally freeze-concentrated solutions (Tg'), to avoid protein aggregation, preserve protein activity, and obtain pharmaceutically 'elegant' cakes. Unfortunately, this is a lengthy and energy-consuming process. However, it was recently shown that drying above Tg' or even above the collapse temperature (Tc) is not necessarily detrimental for stability of biopharmaceuticals, and hence provides an attractive option for freeze-drying cycle optimisation. The goal of the present study was to optimise the freeze-drying cycle for a model IgG monoclonal antibody (20 mg/mL) in sucrose and sucrose/glycine formulations, by reducing primary drying time. To study the impact of shelf temperature (Ts) and chamber pressure on product temperature (Tp), one conventional and five aggressive cycles were tested. Aggressive conditions during primary drying were achieved by increasing Ts from -20 °C (conventional cycle) to 30 °C, with chamber pressure set to 0.1 mbar, 0.2 mbar or 0.3 mbar. These combinations of Ts and chamber pressure resulted in Tp well above Tg', and in some cases, even above Tc, without causing macrocollapse. Other critical quality attributes of the products were also within the expected ranges, such as reconstitution time and residual water content. Physical stability was tested using size exclusion chromatography, dynamic light scattering, and micro-flow imaging. All of the lyophilised samples were exposed to stress and the intended storage conditions, with no impacts on the product seen. These data show that implementation of aggressive conditions for the investigated formulations is possible and can significantly contribute to the reduction of primary drying times by up to 54% (from 48 to 22 h) in comparison to conventional freeze-drying.

Directional freezing and thawing of biologics in drug substance bottles

Optimization of Methodologies to Study Freeze/Thaw Processes in Drug Substance Bottles

Controlling three‐dimensional ice template via two‐dimensional surface wetting

Characterization of Freezing Processes in Drug Substance Bottles by Ice Core Sampling

Facilitating high pressure phase-transition research and kinetics studies at subzero temperatures using self-cooling laboratory units.

The importance of heat flow direction for reproducible and homogeneous freezing of bulk protein solutions

Tuning, measurement and prediction of the impact of freezing on product morphology: A step toward improved design of freeze-drying cycles

Freeze–thaw characterization process to minimize aggregation and enable drug product manufacturing of protein based therapeutics

Impact of controlled vacuum induced surface freezing on the freeze drying of human plasma

Development of a Single Vial Mass Flow Rate Monitor to Assess Pharmaceutical Freeze Drying Heterogeneity

Raman spectroscopy as a process analytical technology to investigate biopharmaceutical freeze concentration processes

Exploring the use of atmospheric freeze drying for dehydrating pharmaceutics in vials: Baseline water sublimation investigation

Premelting-directed interfacial design of nanoshell-coated cells in directional freezing and thawing

Application of physical field-assisted freezing and thawing to mitigate damage of frozen food.

Surface Treatment of Glass Vials for Lyophilization: Implications for Vacuum-Induced Surface Freezing

Aggressive conditions during primary drying as a contemporary approach to optimise freeze-drying cycles of biopharmaceuticals

Numerical Simulation of Selective Freezing of Target Biological Tissues Following Injection of Solutions with Specific Thermal Properties

The Directional Freezing Effects on Biological Cells in A Microfluidic Cell Culture System

Recent advances in freeze-drying: variables, cycle optimization, and innovative techniques

Heat and mass transfer scale-up issues during freeze drying: II. Control and characterization of the degree of supercooling

Freezing Curve-Based Monitoring to Quickly Evaluate the Viability of Biological Materials Subject to Freezing or Thermal Injury